News for June 2011

News Archive

Therapeutic peptides – a revival of interest Therapeutic peptides – a revival of interest

The innovation process in the pharmaceutical industry is, as for all evolutionary models of technological change, both ‘pushed by technology’ and ‘demand driven’. The core of the innovation relies on the research for new high value-added drugs to address unmet medical needs. To this end, tens of billions of dollars are invested per year in R&D. However, the decreasing number of approved drugs, which is accompanied by increasing R&D expenditures, demands alternative approaches to increase R&D productivity. This situation contributes to a revival of interest in peptides as potential tools and drug candidates.

Horizon successfully completes pilot human gene-editing program with leading pharma Horizon successfully completes pilot human gene-editing program with leading pharma

Horizon Discovery (Horizon), a leading provider of research tools to support the development of personalized medicines, has announced that it has successfully completed an eighteen month pilot program with Novartis, designed to test the ability of Horizon’s GENESISTM rAAV gene-editing platform to generate human isogenic cell lines for use by Novartis pre-clinical research programs.

Target of 15 million people on HIV treatment by 2015 secured at AIDS summit

A global United Nations Summit on AIDS has taken a critical step by committing to reach 15 million people with HIV treatment by 2015.

Research and development into tumour profiling will lead to improved cancer care Research and development into tumour profiling will lead to improved cancer care

Six new collaborative research and development projects are set to receive nearly £6 million of government funding in the latest stage of a major five-year initiative to ensure that the UK is a world leader in the development of personalised medicine.

Encouraging Data on the Immune Response to the New Men B Vaccine in Tots and Teens Encouraging Data on the Immune Response to the New Men B Vaccine in Tots and Teens

Meningitis Research Foundation (MRF) welcomes new data released today by Novartis Vaccines and Diagnostics, revealing a robust immune response in babies, toddlers and teenagers to their new Men B vaccine candidate (4CMenB), currently submitted for licence to the EMA.

First female scientist appointed Deputy Government Chemist First female scientist appointed Deputy Government Chemist

LGC, the international market leader in analytical, forensic and diagnostic services and reference standards, announces the appointment of Selvarani Elahi as Deputy Government Chemist.

New treatment hope for diabetes and cardiovascular diseases New treatment hope for diabetes and cardiovascular diseases

A cutting-edge research project at the University of Leicester is aiming to improve the treatment of diabetes and cardiovascular diseases.